Cooper, living with Dravet syndrome
Taking FINTEPLA since 2016
Your loved one’s safety comes first
Understand FINTEPLA’s safety profile and prepare for discussions with your healthcare provider.
Your loved one’s safety comes first
FINTEPLA REMS was designed with your loved one’s safety in mind
FINTEPLA is available only through FINTEPLA REMS due to the risk of potential problems with valves in the heart (valvular heart disease) and high blood pressure in the arteries of the lungs (pulmonary arterial hypertension).
Your loved one’s doctor will order heart tests (echocardiograms) before, during, and one time after the last dose to check for any potential changes in heart function.
Support is available through ONWARD® for identifying where to get these required echocardiograms, whether that is in a doctor’s office, echocardiogram facility, or at home.
Since the approval of FINTEPLA in June 2020 for seizures associated with Dravet syndrome and March 2022 for seizures associated with LGS, more than 10,000 patients worldwide have been prescribed FINTEPLA.
REMS, Risk Evaluation and Mitigation Strategy.
Not a real patient
Learn about proactively monitoring your loved one
Risk Evaluation and Mitigation Strategy (REMS)
LEARN MORE BEFORE YOUR LOVED ONE’S FIRST ECHO
Meet Fin and Willow! In this story, these whimsical characters go to an echocardiogram appointment. Their adventures can help guide the whole family in discussions about this important test—what to expect, why it matters, and more.
While taking FINTEPLA, your loved one with Dravet syndrome may experience some or all of the most common side effects listed below:
The most common side effects of FINTEPLA for DS:
- Decreased appetite
- Diarrhea
- Low energy
- Respiratory infection
- Decreased weight
- Fever
- Constipation
- Abnormal echocardiogram
- Sleepiness
- Problems with movement, balance, and walking
- Increased drooling
- Increased blood pressure
- Vomiting
- Falls
- Seizures that do not stop
- Weakness
Most patients with Dravet syndrome resumed expected weight gains during the open-label extension study.
These are not all the possible side effects of FINTEPLA. For more information, ask your healthcare provider or pharmacist. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
Call your healthcare provider for medical advice about side effects.
You may report side effects to the FDA at 1-800-FDA-1088.
Looking for more information on
Dravet Syndrome
& FINTEPLA?
Get a free Dravet syndrome patient brochure with all the facts about being on FINTEPLA.
ASK YOUR QUESTIONS IN REAL TIME
ONWARD® offers comprehensive support for patients prescribed FINTEPLA.
